Back
CytomX Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CTMX
CytomX Therapeutics
Last Price:
0.89
Seasonality Move:
13.92%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTMX is experiencing slight buying pressure.
CytomX Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Sell |
| 20-day SMA: | 0.97 | Sell |
| 50-day SMA: | 1.08 | Sell |
| 200-day SMA: | 1.59 | Sell |
| 8-day EMA: | 0.91 | Sell |
| 20-day EMA: | 0.97 | Sell |
| 50-day EMA: | 1.07 | Sell |
| 200-day EMA: | 1.39 | Sell |
CytomX Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 35.68 | Sell |
| Chaikin Money Flow: | 353351 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.92 - 1.08) | Sell |
| Bollinger Bands (100): | (1.03 - 1.33) | Sell |
CytomX Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytomX Therapeutics Stock
Is CytomX Therapeutics Stock a Buy?
- CytomX Therapeutics share price is 0.89 while CTMX 8-day simple moving average is 0.91, which is a Sell signal.
- The stock price of CTMX is 0.89 while CytomX Therapeutics 20-day SMA is 0.97, which makes it a Sell.
- CytomX Therapeutics 50-day simple moving average is 1.08 while CTMX share price is 0.89, making it a Sell technically.
- CTMX stock price is 0.89 and CytomX Therapeutics 200-day simple moving average is 1.59, creating a Sell signal.
CTMX Technical Analysis vs Fundamental Analysis
Sell
28
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy or a Sell?
-
CytomX Therapeutics stock is rated a Sell
The current CytomX Therapeutics [CTMX] share price is $0.89. The Score for CTMX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
CytomX Therapeutics Stock Info
Market Cap:
69.65M
Price in USD:
0.89
Share Volume:
494.69K
CytomX Therapeutics 52-Week Range
52-Week High:
5.85
52-Week Low:
0.83
Sell
28
CytomX Therapeutics (CTMX)
is a Sell
CytomX Therapeutics Share Price Forecast
-
What is the CytomX Therapeutics stock price today?
The CytomX Therapeutics stock price is 0.89 USD today. -
Will CTMX stock go up or go down?
CytomX Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is CytomX Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytomX Therapeutics is overvalued.
Is CytomX Therapeutics Stock a Buy?
- CytomX Therapeutics share price is 0.89 while CTMX 8-day exponential moving average is 0.91, which is a Sell signal.
- The stock price of CTMX is 0.89 while CytomX Therapeutics 20-day EMA is 0.97, which makes it a Sell.
- CytomX Therapeutics 50-day exponential moving average is 1.07 while CTMX share price is 0.89, making it a Sell technically.
- CTMX stock price is 0.89 and CytomX Therapeutics 200-day simple moving average is 1.39, creating a Sell signal.
Fundamental Analysis of CytomX Therapeutics
Is CytomX Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.44 per share.
Technical Analysis of CytomX Therapeutics
Should I short CytomX Therapeutics stock?
- CTMX Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting CytomX Therapeutics is a Sell
- CytomX Therapeutics Relative Strength Index (RSI) is 35.68, which suggest CytomX Therapeutics is oversold
- The Bollinger Bands (25) for CytomX Therapeutics is (0.92 - 1.08), which suggest CytomX Therapeutics is a Sell
- The Bollinger Bands (100) for CytomX Therapeutics is (1.03 - 1.33), which suggest CytomX Therapeutics is a Sell
* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.